Abstract
sICAM-1 measurements are here shown to be independent of processing method (serum, platelet rich and platelet poor plasma) and sampling size (venous or arterial blood) in patients with coronary disease.
Similar content being viewed by others
References
Madej A, Okopien B, Kowalski J, Haberka M, Herman ZS (2005) Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension. Pharmacol Rep 57:878–881
Silvestro A, Brevetti G, Schiano V, Scopacasa F, Chiariello M (2005) Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification. Thromb Haemost 93:559–563
Parissis JT, Adamopoulos S, Venetsanou K et al (2004) Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction. Eur Cytokine Netw 15:139–144
Murohara T, Kamijikkoku S, Honda T (2000) Increased circulating soluble intercellular adhesion molecule-1 in acute myocardial infarction: a possible predictor of reperfusion ventricular arrhythmias. Crit Care Med 28:1861–1864
Kerner T, Ahlers O, Reschreiter H, Buhrer C, Mockel M, Gerlach H (2001) Adhesion molecules in different treatments of acute myocardial infarction. Crit Care 5:145–150
Kaikita K, Ogawa H, Yasue H et al. (1997) Increased plasma soluble intercellular adhesion molecule-1 levels in patients with acute myocardial infarction. Jpn Circ J 61:741–748
Stenvinkel P, Lindholm B, Heinburger M, Heimburger Q (2000) Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 15:1624–1630
Worthley SG, Farouque HM, Cameron JD, Meredith IT (2006) Arterial remodelling correlates positively with serological evidence of inflammation in patients with chronic stable angina pectoris. J Invasive Cardiol 18:28–31
Benson VL, McMahon AC, Lowe HC (2007) sICAM-1 in acute myocardial infarction: a suitable therapeutic target? Curr Mol Med 7:219–227
Varo N, Nuzzo R, Natal C, Libby P, Schonbeck U (2006) Influence of pre-analytical and analytical factors on soluble CD40L measurements. Clin Sci (Lond) 111:341–347
Ahn ER, Lander G, Jy W, Bidot CJ, Jimenez JJ, Horstman LL, Ahn YS (2004) Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk. Thromb Res 114:143–148
Acknowledgements
University of Sydney funding (VLB, HCL).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Benson, V.L., McMahon, A.C. & Lowe, H.C. sICAM-1 measurements are independent of processing method and sampling site in patients with coronary artery disease. J Thromb Thrombolysis 24, 307–308 (2007). https://doi.org/10.1007/s11239-007-0021-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-007-0021-0